Correlation Between Beam TherapeuticsInc and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Beam TherapeuticsInc and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam TherapeuticsInc and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam TherapeuticsInc and Crispr Therapeutics AG, you can compare the effects of market volatilities on Beam TherapeuticsInc and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam TherapeuticsInc with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam TherapeuticsInc and Crispr Therapeutics.
Diversification Opportunities for Beam TherapeuticsInc and Crispr Therapeutics
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Beam and Crispr is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Beam TherapeuticsInc and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Beam TherapeuticsInc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam TherapeuticsInc are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Beam TherapeuticsInc i.e., Beam TherapeuticsInc and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Beam TherapeuticsInc and Crispr Therapeutics
Given the investment horizon of 90 days Beam TherapeuticsInc is expected to under-perform the Crispr Therapeutics. In addition to that, Beam TherapeuticsInc is 1.31 times more volatile than Crispr Therapeutics AG. It trades about -0.27 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.21 per unit of volatility. If you would invest 6,290 in Crispr Therapeutics AG on February 5, 2024 and sell it today you would lose (701.00) from holding Crispr Therapeutics AG or give up 11.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Beam TherapeuticsInc vs. Crispr Therapeutics AG
Performance |
Timeline |
Beam TherapeuticsInc |
Crispr Therapeutics |
Beam TherapeuticsInc and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Beam TherapeuticsInc and Crispr Therapeutics
The main advantage of trading using opposite Beam TherapeuticsInc and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam TherapeuticsInc position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.Beam TherapeuticsInc vs. Quoin Pharmaceuticals Ltd | Beam TherapeuticsInc vs. Morningstar Unconstrained Allocation |
Crispr Therapeutics vs. Quoin Pharmaceuticals Ltd | Crispr Therapeutics vs. Morningstar Unconstrained Allocation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |